Advertisement
Last Articles
Last News
NICE backs Roche cancer drug for wider use
LONDON (Reuters) - British patients with advanced follicular lymphoma, a blood cancer, will have more treatment options after the health funding watchdog recommended Roche's drug MabThera for use with more chemotherapy regimens.<img width='1' height='1' src='http://mf.feeds.reuters.com/c/871/f/415342/s/17f7c7d0/mf.gif' border='0'/><div class='mf-viral'><table border='0'><tr><td valign='middle'><a href="http://res.feedsportal.com/viral/sendemail2.html?title=NICE+backs+Roche+cancer+drug+for+wider+use&link=http%3A%2F%2Fuk.reuters.com%2Farticle%2F2011%2F09%2F04%2Fuk-roche-mabthera-idUKTRE7832JG20110904%3FfeedType%3DRSS%26feedName%3DtopNews" target="_blank"><img src="http://res3.feedsportal.com/images/emailthis2.gif" border="0" /></a></td><td valign='middle'><a href="http://res.feedsportal.com/viral/bookmark.cfm?title=NICE+backs+Roche+cancer+drug+for+wider+use&link=http%3A%2F%2Fuk.reuters.com%2Farticle%2F2011%2F09%2F04%2Fuk-roche-mabthera-idUKTRE7832JG20110904%3FfeedType%3DRSS%26feedName%3DtopNews" target="_blank"><img src="http://res3.feedsportal.com/images/bookmark.gif" border="0" /></a></td></tr></table></div><br/><br/><a href="http://da.feedsportal.com/r/111974075540/u/0/f/415342/c/871/s/17f7c7d0/a2.htm"><img src="http://da.feedsportal.com/r/111974075540/u/0/f/415342/c/871/s/17f7c7d0/a2.img" border="0"/></a> [More]